MABS
Clinical trial matching for cell therapy makers.
Odds to close a Series B in 12 months38.0%Range 31%–46%
22 of 24 applicable signals known, high confidence
0.0 today0.0 30 days
Unlikely
+4.3 pts over the past 180 days
Last roundSeries A, $17M
Led byLux Capital
Months since29
Total raised$22.1M
Headcount26
Founded2024
Factors
Factors are groups of signals that can contribute to a company’s success. Each is marked positive or negative for its odds. They’re indicators, not guarantees; together, and tested against real outcomes, they become predictive.
Founders48Neutral5 of 6 signals known
Traction49Neutral3 of 3 signals known
Hiring48Neutral4 of 5 signals known
Capital68Positive4 of 4 signals known
Network60Positive3 of 3 signals known
Product50Neutral3 of 3 signals known
SignalValue
Capital3 of 4 pushing up+0.54 net
Network1 of 3 pushing up+0.29 net
Product2 of 3 pushing up+0.00 net
Traction0 of 3 pushing up−0.03 net
Founders1 of 6 pushing up−0.04 net
Hiring0 of 5 pushing up−0.06 net
3 signals don’t apply to Health & bio companies at Series A and aren’t counted.